KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) EBT (2016 - 2026)

Insulet filings provide 16 years of EBT readings, the most recent being $140.2 million for Q4 2025.

  • On a quarterly basis, EBT rose 25.85% to $140.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $339.5 million, a 13.05% increase, with the full-year FY2025 number at $339.5 million, up 13.09% from a year prior.
  • EBT hit $140.2 million in Q4 2025 for Insulet, up from $122.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $140.2 million in Q4 2025 to a low of -$36.1 million in Q2 2022.
  • Median EBT over the past 5 years was $31.4 million (2021), compared with a mean of $44.2 million.
  • Biggest five-year swings in EBT: plummeted 263.22% in 2021 and later soared 9666.67% in 2022.
  • Insulet's EBT stood at $33.4 million in 2021, then plummeted by 33.23% to $22.3 million in 2022, then skyrocketed by 383.86% to $107.9 million in 2023, then rose by 3.24% to $111.4 million in 2024, then rose by 25.85% to $140.2 million in 2025.
  • The last three reported values for EBT were $140.2 million (Q4 2025), $122.8 million (Q3 2025), and $28.4 million (Q2 2025) per Business Quant data.